GB1182008A - Resolution of d1-(3-Trifluoromethylphenoxy)-(4-Chlorophenyl)Acetic Acid - Google Patents
Resolution of d1-(3-Trifluoromethylphenoxy)-(4-Chlorophenyl)Acetic AcidInfo
- Publication number
- GB1182008A GB1182008A GB44021/67A GB4402167A GB1182008A GB 1182008 A GB1182008 A GB 1182008A GB 44021/67 A GB44021/67 A GB 44021/67A GB 4402167 A GB4402167 A GB 4402167A GB 1182008 A GB1182008 A GB 1182008A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acid
- chlorophenyl
- salt
- acetic acid
- trifluoromethylphenoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58393966A | 1966-10-03 | 1966-10-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1182008A true GB1182008A (en) | 1970-02-25 |
Family
ID=24335229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB44021/67A Expired GB1182008A (en) | 1966-10-03 | 1967-09-27 | Resolution of d1-(3-Trifluoromethylphenoxy)-(4-Chlorophenyl)Acetic Acid |
Country Status (3)
Country | Link |
---|---|
CH (1) | CH487101A (zh) |
GB (1) | GB1182008A (zh) |
NL (1) | NL6712585A (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000074666A2 (en) * | 1999-06-04 | 2000-12-14 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia |
EP1343493A2 (en) * | 2000-11-28 | 2003-09-17 | Metabolex, Inc. | Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
EP1635809A1 (en) * | 2003-06-20 | 2006-03-22 | Metabolex, Inc. | Resolution of alpha-(phenoxy)phenylacetic acid derivatives |
US7199259B2 (en) * | 2003-06-20 | 2007-04-03 | Metabolex, Inc. | Resolution of α-(phenoxy)phenylacetic acid derivatives |
US7576131B2 (en) | 1999-06-04 | 2009-08-18 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
US7714131B2 (en) | 2005-09-23 | 2010-05-11 | Metabolex, Inc. | Process for the stereoselective preparation of (−)-halofenate and derivatives thereof |
-
1967
- 1967-09-14 NL NL6712585A patent/NL6712585A/xx unknown
- 1967-09-27 GB GB44021/67A patent/GB1182008A/en not_active Expired
- 1967-10-02 CH CH1369867A patent/CH487101A/de not_active IP Right Cessation
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1614418A1 (en) * | 1999-06-04 | 2006-01-11 | Metabolex, Inc. | use of(-)(3-trihalomethylphenoxy) (4-halophenyl)acetic acid derivatives for treatment of hyperuricaemia |
US7576131B2 (en) | 1999-06-04 | 2009-08-18 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
WO2000074666A2 (en) * | 1999-06-04 | 2000-12-14 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia |
JP2003501383A (ja) * | 1999-06-04 | 2003-01-14 | メタボレックス, インコーポレイテッド | インスリン抵抗性、2型糖尿病、高脂血症および高尿酸血症の処置のための、(−)(3−トリハロメチルフェノキシ)(4−ハロフェニル)酢酸誘導体の使用 |
US6613802B1 (en) | 1999-06-04 | 2003-09-02 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
US6262118B1 (en) | 1999-06-04 | 2001-07-17 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
US6624194B1 (en) | 1999-06-04 | 2003-09-23 | Metabolex, Inc. | Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
US6646004B1 (en) | 1999-06-04 | 2003-11-11 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
WO2000074666A3 (en) * | 1999-06-04 | 2001-11-08 | Metabolex Inc | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia |
US8481597B2 (en) | 1999-06-04 | 2013-07-09 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
US8354448B2 (en) | 1999-06-04 | 2013-01-15 | Metabolex, Inc. | Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes |
US8329749B2 (en) | 1999-06-04 | 2012-12-11 | Metabolex, Inc. | Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia |
JP2007099784A (ja) * | 1999-06-04 | 2007-04-19 | Metabolex Inc | インスリン抵抗性、2型糖尿病、高脂血症および高尿酸血症の処置のための、(−)(3−トリハロメチルフェノキシ)(4−ハロフェニル)酢酸誘導体の使用 |
EP1343493A2 (en) * | 2000-11-28 | 2003-09-17 | Metabolex, Inc. | Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
EP1343493A4 (en) * | 2000-11-28 | 2009-06-24 | Metabolex Inc | USE OF (-) (3-HALOMETHYLPHENOXY) (4-HALOPHENYL) ACETIC ACID DERIVATIVES IN THE TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES, HYPERLIPIDEMIA AND HYPERURICEMIA |
EP1635809A4 (en) * | 2003-06-20 | 2006-09-27 | Metabolex Inc | RESOLUTION OF ALPHA (PHENOXY) PHENYLACETIC ACID DERIVATIVES |
US7199259B2 (en) * | 2003-06-20 | 2007-04-03 | Metabolex, Inc. | Resolution of α-(phenoxy)phenylacetic acid derivatives |
EP1635809A1 (en) * | 2003-06-20 | 2006-03-22 | Metabolex, Inc. | Resolution of alpha-(phenoxy)phenylacetic acid derivatives |
US7714131B2 (en) | 2005-09-23 | 2010-05-11 | Metabolex, Inc. | Process for the stereoselective preparation of (−)-halofenate and derivatives thereof |
Also Published As
Publication number | Publication date |
---|---|
CH487101A (de) | 1970-03-15 |
NL6712585A (zh) | 1968-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1182008A (en) | Resolution of d1-(3-Trifluoromethylphenoxy)-(4-Chlorophenyl)Acetic Acid | |
GB1448316A (en) | Racemization of optically active 2,2-dimethyl-3,1,-alkenyl- cyclopropane-1-carboxylic acids | |
GB1380065A (en) | 5-amino-isophthalic acid derivatives | |
GB1097532A (en) | Improvements in or relating to the preparation of cyclopentane derivatives | |
GB1272606A (en) | Imidazolinyl benzalhydrazone and a process for its preparation | |
GB1202120A (en) | A method of preparing comenic acid | |
GB1245436A (en) | Process for the preparation of a salt of optically active lysine | |
GB1226914A (zh) | ||
GB1273288A (en) | Substituted benzoic acid lactone derivatives | |
GB1472396A (en) | Resolution of 2-deutero-3-fluoroalanine | |
GB1191100A (en) | Preparation of Optically Active Isomers of Lysines | |
GB1468333A (en) | Ketoglutaric acid derivatives | |
GB1156465A (en) | Prostaglandins | |
GB1241405A (en) | Resolution of phenylalanine derivatives | |
GB1232659A (zh) | ||
GB1284423A (en) | Cyclohexa-1,4-diene-1-acetic acids | |
GB1126605A (en) | New amino derivatives of gentisic acid and processes of production | |
GB1127868A (en) | The preparation of c alkyl esters of ª‡-methyl-ª‡-cyano-ªß-(3,4-disubstituted phenyl)propionic acids | |
GB1181547A (en) | Process for Optically Resolving DL-Glutamic Acid and Salts thereof. | |
GB1374350A (en) | Racemic separation of acetic acid derivative | |
GB1323939A (en) | Phenylalanine derivatives and their preparation | |
GB1254061A (en) | Optical separation of methionine nitrile | |
GB1418870A (en) | Resolution of dl-a-aminophenylacetic-acid | |
GB1225806A (zh) | ||
GB1332090A (en) | Optical resolution of salts of dl-2-pyrolidone-5-carboxylic acid |